 |
| “Talk to your doctor to see if [insert drug name] is right for you.” One glance at the television screen tells the story: a shot of the outdoors hints at allergy medications like Claritin, a laughing couple winks for Viagra, and a wind-up toy symbolizes the depressive symptoms treated by antidepressants like Pristiq. With familiar voice-over scripts and images of smiling (read: hired) actors, advertisements for prescription drugs flood our daily consumption of media. One Kantar analysis revealed that 72 percent of commercial breaks during CBS Evening News, and 62 percent of commercial breaks during the television show General Hospital, include at least one advertisement for pharmaceutical products. Vowing to treat a host of common conditions ranging from arthritis to diabetes to erectile dysfunction, pharmaceutical advertisements have become an established norm in our cultural landscape. However, their seemingly ubiquitous nature belies the fact that direct-to-consumer pharmaceutical advertising is banned in virtually every country except the United States and New Zealand. This form of advertising refers to the marketing of pharmaceutical drugs to patients, rather than healthcare providers, through a wide variety of multimedia channels, from television to social media to print publications. A closer look at the history of DTCPA reveals that consumer-targeted advertising was not always an embedded norm of pharmaceutical promotion. Rather, a balanced set of risks and benefits has complicated this debate for decades, folding into long-term questions over consumer-oriented care and freedom of commercial speech. Meanwhile, spending on pharmaceutical advertisements has swelled by 62 percent since 2012, alongside skyrocketing costs of prescription drugs, projected to reach as high as $610 billion by 2021. With increasing pressure from the American public to manage growing healthcare costs, the role of DTCPA in the U.S. economic and cultural landscape warrants further investigation. Read More Related |
https://prescriptiondrugs.procon.org/
https://www.psychologytoday.com/us/blog/side-effects/201605/the-effort-rid-tv-pharma-ads
https://www.quora.com/Why-are-there-so-many-advertisements
https://www.cbsnews.com/news/drug-ads-5-2-billion-annually-and-rising/
No comments:
Post a Comment